Vanillin-based functionalization strategy to construct multifunctional microspheres for treating inflammation and regenerating intervertebral disc
Bioactive Materials · 2023-10 · 28 · 167-182
DOI: 10.1016/j.bioactmat.2023.05.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioactive Materials, 2023-10. Verfasst von Zhuang Zhu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Orthopedic Institute, Department of Orthopedic Surgery, The First Affiliated Hospital, School of Biology & Basic Medical Sciences, Suzhou Medical Col…. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Priority Academic Program Development of Jiangsu Higher Education Institutions.
Abstract (Originalsprache)
Intervertebral disc degeneration (IVDD) is one of the main causes of low back pain. Although local delivery strategies using biomaterial carriers have shown potential for IVDD treatment, it remains challenging for intervention against multiple adverse contributors by a single delivery platform. In the present work, we propose a new functionalization strategy using vanillin, a natural molecule with anti-inflammatory and antioxidant properties, to develop multifunctional gelatin methacrylate (GelMA) microspheres for local delivery of transforming growth factor β3 (TGFβ3) toward IVDD treatment. In vitro, functionalized microspheres not only improved the release kinetics of TGFβ3 but also effectively inhibited inflammatory responses and promoted the secretion of extracellular matrix (ECM) in lipopolysaccharide-induced nucleus pulposus (NP) cells. In vivo, functionalized platform plays roles in alleviating inflammation and oxidative stress, preserving the water content of NP and disc height, and maintaining intact structure and biomechanical functions, thereby promoting the regeneration of IVD. High-throughput sequencing suggests that inhibition of the phosphatidylinositol 3-kinase (PI3K)-Akt signaling might be associated with their therapeutic effects. In summary, the vanillin-based functionalization strategy provides a novel and simple way for packaging multiple functions into a single delivery platform and holds promise for tissue regeneration beyond the IVD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Orthopedic Institute, Department of Orthopedic Surgery, The First Affiliated Hospital, School of Biology & Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Jiangsu, 215007, China.
- Children's Hospital of Soochow University, Pediatric Research Institute of Soochow University, Suzhou, Jiangsu, 215123, China.
- Institute of Functional Nano & Soft Materials, Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou, Jiangsu, 215123, China.
Förderung
- National Natural Science Foundation of China
- Priority Academic Program Development of Jiangsu Higher Education Institutions
Zitieren
APA
Zhu, Z., Yu, Q., Li, H., Han, F., Guo, Q., Sun, H., Zhao, H., Tu, Z., Liu, Z., Zhu, C., & Li, B. (2023). Vanillin-based functionalization strategy to construct multifunctional microspheres for treating inflammation and regenerating intervertebral disc. Bioactive Materials, 28, 167-182. https://doi.org/10.1016/j.bioactmat.2023.05.005
Vancouver
Zhu Z, Yu Q, Li H, Han F, Guo Q, Sun H, et al. Vanillin-based functionalization strategy to construct multifunctional microspheres for treating inflammation and regenerating intervertebral disc. Bioactive Materials. 2023;28:167-182. doi:10.1016/j.bioactmat.2023.05.005
BibTeX
@article{Zhu2023,
author = {Zhu, Zhuang and Yu, Qifan and Li, Hanwen and Han, Feng and Guo, Qianping and Sun, Heng and Zhao, He and Tu, Zhengdong and Liu, Zhuang and Zhu, Caihong and Li, Bin},
title = {Vanillin-based functionalization strategy to construct multifunctional microspheres for treating inflammation and regenerating intervertebral disc},
journal = {Bioactive Materials},
year = {2023},
volume = {28},
pages = {167--182},
doi = {10.1016/j.bioactmat.2023.05.005}
}
EUVIMED